Association of Tumour Microenvironment with Protein Glycooxidation, DNA Damage, and Nitrosative Stress in Colorectal Cancer.

colorectal cancer nitrosative stress oxidative stress redox biomarkers

Journal

Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700

Informations de publication

Date de publication:
2021
Historique:
received: 05 05 2021
accepted: 10 07 2021
entrez: 19 8 2021
pubmed: 20 8 2021
medline: 20 8 2021
Statut: epublish

Résumé

In this study, we evaluated the total antioxidant capacity, nitrosative stress, and protein/DNA oxidation and glycoxidation products in patients with colorectal cancer regarding histopathological parameters associated with the tumour microenvironment, such as inflammatory infiltration and tumour budding and compare all determined parameters between tumours located in the right and left side of the colon and normal mucosa. Ferric reducing antioxidant power (FRAP), nitrosative stress (myeloperoxidase (MPO), nitrogen oxide (NO), peroxynitrite, and nitrotyrosine), protein oxidation products (protein carbonyls (PC), total thiols, and ischemia modified albumin (IMA)), protein glycooxidation products (tryptophan, kynurenine, N-formylkynurenine, dityrosine, Amadori product, advanced glycation end products (AGE)) and 8-hydroxydeoxyguanosine (8-OHdG) were measured in homogenates from normal and cancerous tissue of 30 patients with colorectal cancer. Levels of FRAP (p=0.0009), IMA (p=0.0002), kynurenine (p<0.0001), N-formylkynurenine (p<0.0001), dityrosine (p<0.0001), Amadori products (p=0.0024), AGE (p<0.0001), MPO (p<0.0001), NO (p<0.0001) and nitrotyrosine (p=0.0011) were increased, whereas PC (p=0.0004), tryptophan (p<0.0001), 8-OHdG (p<0.0001) and peroxynitrite (p=0.0003) were decreased in the left-side tumour compared to the right-side tumour and normal mucosa. Our results showed that colorectal cancer is related with disturbances in antioxidant defense and increased oxidative and nitrosative damages to proteins and DNA. These parameters may be useful for evaluation the progression and differentiation of the tumour location. We also demonstrated that redox indicators may depend on the histological type of the tumour and may influence tumour invasion depth, presence of lymph node and distant metastasis, vascular and neural invasion, inflammatory infiltration, and tumour budding, which are part of the tumour microenvironment.

Identifiants

pubmed: 34408493
doi: 10.2147/CMAR.S314940
pii: 314940
pmc: PMC8366958
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6329-6348

Informations de copyright

© 2021 Zińczuk et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Semin Cancer Biol. 2018 Apr;49:44-55
pubmed: 28712719
Methods Enzymol. 1994;233:357-63
pubmed: 8015470
Ann Intern Med. 1990 Nov 15;113(10):779-88
pubmed: 2240880
Free Radic Biol Med. 2013 Sep;62:170-185
pubmed: 23000246
Lab Invest. 2016 Dec;96(12):1268-1278
pubmed: 27775688
Front Physiol. 2017 Jan 26;8:20
pubmed: 28184199
Toxicol Appl Pharmacol. 2011 Jul 15;254(2):86-99
pubmed: 21296097
J Clin Med. 2019 Jun 12;8(6):
pubmed: 31212834
Biochem Pharmacol. 2006 Oct 30;72(9):1180-95
pubmed: 16997282
Redox Biol. 2018 Apr;14:618-625
pubmed: 29154193
Cancers (Basel). 2014 May 09;6(2):1111-27
pubmed: 24821130
Antioxid Redox Signal. 2010 Mar;12(3):323-5
pubmed: 19743917
J Proteomics. 2013 Oct 30;92:228-38
pubmed: 23459210
World J Surg Oncol. 2013 May 30;11:118
pubmed: 23718886
Science. 2002 Jun 28;296(5577):2391-4
pubmed: 12089442
Folia Histochem Cytobiol. 2009;47(4):621-5
pubmed: 20430730
Cancer. 2009 Aug 1;115(15):3379-91
pubmed: 19484787
J Pathol. 2003 Sep;201(1):17-27
pubmed: 12950013
Mediators Inflamm. 2004 Dec;13(5-6):381-3
pubmed: 15770058
Mutat Res. 2009 Mar 31;674(1-2):36-44
pubmed: 18977455
Anal Biochem. 1996 Jul 15;239(1):70-6
pubmed: 8660627
Int J Cell Biol. 2012;2012:762825
pubmed: 22666258
Prostate Cancer Prostatic Dis. 2007;10(4):356-9
pubmed: 17404581
Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Methods Enzymol. 1996;268:237-46
pubmed: 8782590
Cell Stress. 2020 Jan 03;4(1):24-26
pubmed: 31922097
Clin Cancer Res. 2006 Feb 15;12(4):1201-7
pubmed: 16489074
Antioxidants (Basel). 2020 Nov 04;9(11):
pubmed: 33158288
Toxicol Rep. 2017 May 31;4:291-295
pubmed: 28959652
Arch Biochem Biophys. 1992 Nov 1;298(2):438-45
pubmed: 1416975
Int J Oncol. 2017 Apr;50(4):1191-1200
pubmed: 28260049
Curr Biol. 2014 May 19;24(10):R453-62
pubmed: 24845678
Adv Immunol. 1997;65:1-46
pubmed: 9238507
Front Physiol. 2017 Jun 07;8:386
pubmed: 28638348
Ir J Med Sci. 2017 Feb;186(1):57-62
pubmed: 27156054
BMC Cancer. 2002 Apr 29;2:8
pubmed: 11978184
J Transl Med. 2019 Jul 23;17(1):239
pubmed: 31337401
Nutr J. 2016 Jul 25;15(1):71
pubmed: 27456681
Mutat Res. 2005 Nov 11;579(1-2):37-46
pubmed: 16084533
Clin Chem. 1987 Oct;33(10):1955-6
pubmed: 3665082
Cell Res. 2002 Dec;12(5-6):311-20
pubmed: 12528889
Dan Med J. 2012 Jun;59(6):A4444
pubmed: 22677242
Methods Enzymol. 1999;301:201-11
pubmed: 9919568
Mod Pathol. 2017 Sep;30(9):1299-1311
pubmed: 28548122
Int Urol Nephrol. 2003;35(3):345-50
pubmed: 15160536
Bioessays. 2005 Dec;27(12):1228-38
pubmed: 16299735
Oxid Med Cell Longev. 2020 Sep 9;2020:1057570
pubmed: 32963689
Antioxidants (Basel). 2020 May 01;9(5):
pubmed: 32369921
Cancer Res. 2018 Nov 1;78(21):6040-6047
pubmed: 30327380
Drug Metab Rev. 1998 May;30(2):225-43
pubmed: 9606602
Cancers (Basel). 2020 Jun 20;12(6):
pubmed: 32575703
Int J Mol Sci. 2020 Oct 29;21(21):
pubmed: 33137990
Redox Biol. 2014 Jan 09;2:411-29
pubmed: 24624331
J Clin Med. 2019 Jan 21;8(1):
pubmed: 30669680
Gastroenterology Res. 2018 Aug;11(4):264-273
pubmed: 30116425
J Cell Mol Med. 2007 Sep-Oct;11(5):1138-48
pubmed: 17979889
Chem Biol Interact. 2014 Dec 5;224:164-75
pubmed: 25452175
Am J Surg Pathol. 2012 Feb;36(2):193-201
pubmed: 22251938
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Lancet Oncol. 2001 Mar;2(3):149-56
pubmed: 11902565
Recent Pat Inflamm Allergy Drug Discov. 2009 Jan;3(1):73-80
pubmed: 19149749
Oral Dis. 2014 Sep;20(6):560-6
pubmed: 24106991
Biomarkers. 2017 Nov;22(7):629-634
pubmed: 27775438

Auteurs

Justyna Zińczuk (J)

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, 15-269, Poland.

Konrad Zaręba (K)

2nd Clinical Department of General and Gastroenterological Surgery, Medical University of Bialystok, Białystok, 15-276, Poland.

Joanna Kamińska (J)

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, 15-269, Poland.

Olga Martyna Koper-Lenkiewicz (OM)

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, 15-269, Poland.

Violetta Dymicka-Piekarska (V)

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, 15-269, Poland.

Anna Pryczynicz (A)

Department of General Pathomorphology, Medical University of Bialystok, Białystok, 15-269, Poland.

Katarzyna Guzińska-Ustymowicz (K)

Department of General Pathomorphology, Medical University of Bialystok, Białystok, 15-269, Poland.

Boguław Kędra (B)

2nd Clinical Department of General and Gastroenterological Surgery, Medical University of Bialystok, Białystok, 15-276, Poland.

Joanna Matowicka-Karna (J)

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Białystok, 15-269, Poland.

Małgorzata Żendzian-Piotrowska (M)

Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Białystok, 15-222, Poland.

Anna Zalewska (A)

Independent Laboratory of Experimental Dentistry, Medical University of Bialystok, Białystok, 15-276, Poland.

Mateusz Maciejczyk (M)

Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Białystok, 15-222, Poland.

Classifications MeSH